丁香园AV

Reprinted with permission from 丁香园AV News. Original post here.

A new research group based at 丁香园AV has received a major funding grant totalling $14.6 million to help support public confidence in and access to vaccines, in preparation for future pandemics.

The Social Sciences and Humanities (SSH) Consortium will be led by Kelley Lee, professor in 丁香园AV鈥檚 Faculty of Health Sciences, alongside co-director 脠ve Dub茅, adjunct professor in the Faculty of Social Sciences at Universit茅 Laval. The funding comes from the , and the .

The SSH Consortium will bring together leading social scientists from across Canada and globally to better understand and support confidence in, and equitable access to, vaccines and other immune-based innovations. This work will support the rapidly advancing field of immuno-engineering, which has the potential to develop new lifesaving and health promoting vaccines and therapeutics.

鈥淎longside the successful development of innovative products, there is a need to support optimal uptake by the people who need them,鈥� says Lee. 鈥淲e learned during the COVID-19 pandemic that new vaccines not only need to be safe and effective, but they must also be socially acceptable and accessible.鈥�

Biomanufacturing will be a key component for effectively responding to future pandemic events.  The SSH Consortium will strengthen biomanufacturing in Canada by bridging across the life and bioengineering sciences, public health community, and Canadian society. The team will conduct research to better understand diverse perspectives across the biomanufacturing pipeline, immunization system and wider public. Findings will support knowledge mobilization activities that reduce mis/disinformation, enhance vaccine confidence, and promote equitable access.

鈥淭here鈥檚 a famous expression saying that it鈥檚 vaccination, not vaccines, that prevents diseases. But there is no 鈥榦ne-size-fits-all鈥� solution to enhance vaccine acceptance and uptake,鈥� says Dub茅. 鈥淭his project will generate insights on local communities鈥� views, values and needs that are crucial to develop tailored interventions to build trust in new vaccines or therapeutics.鈥�

The SSH Consortium will bring together expertise in epidemiology, anthropology, communications, political science, history, law, philosophy, sociology and other fields. The team will work together to understand perspectives, attitudes and needs towards immune-based innovations.

Health equity will be a high priority.  The project will seek to understand the concerns of priority populations, such as Indigenous peoples, racialized communities, rural and remote communities, related to the acceptability and accessibility of new vaccines and therapeutics.